Detection of non‐native species formed during fibrillization of the myocilin olfactomedin domain
Year: 2025
Type: article
Abstract: Glaucoma is a group of neurodegenerative diseases that together are the leading cause of irreversible blindness worldwide. Myocilin-associated glaucoma is an inherited form of this disease, caused by intracellular aggregation of misfolded mutant myocilin. In vitro, the myocilin C-terminal olfactomedin domain (OLF), the relevant domain for glaucoma pathogenesis, can be driven to form amyloid-like fibrils under mild conditions. Here we characterize a species present during in vitro fibrillization. Purified OLF was subjected to fibrillization at concentrations required for downstream electron microscopy imaging and NMR spectroscopy. Additional biophysical techniques, including analytical ultracentrifugation and X-ray crystallography, were employed to further characterize the multicomponent mixture. Negative stain transmission electron microscopy (TEM) shows a non-native species reminiscent of known prefibrillar oligomers from other amyloid systems, NMR indicates a minor population of partially misfolded species is present in solution, and cryo-EM imaging shows two-dimensional protein arrays. The predominant soluble species remaining in solution after the fibril reaction is natively folded, as evidenced by X-ray crystallography. In summary, after incubating OLF under fibrillization-promoting conditions, there is a heterogeneous mixture consisting of soluble folded protein, mature amyloid-like fibrils, and partially misfolded intermediate species that at present belie additional molecular detail. The characterization of OLF fibrillar species illustrates the challenges associated with developing a comprehensive understanding of the fibrillization process for large, non-model amyloidogenic proteins.
Source: Protein Science
DOI: 10.1002/pro.70063
Authors: Hailee F. Scelsi, Emily G. S. Close, Dustin J. E. Huard, Elijah Dunn, Nebojša Bogdanović, Sonali H. W. Mudiyanselage, Arshay Grant, Scott M. Stagg, Ingeborg Schmidt‐Krey, Wade D. Van Horn, Raquel L. Lieberman
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
Awards: G1699008898, Phase II SER-CAT Optimization: Acquisition of a next generation area detector, G2302316395, G241279073, Acquisition of a High Precision Micro Diffractometer to Support NIH funded Research at SER-CAT, An Eiger2 XE 9M detector for the NYSBC-operated NYX beamline at NSLS-II, G6095956008, G6153725424, G6440026321, G7237386365, Molecular Mechanisms and Regulation Networks of TRPM8, Acquition of a microdiffractometer for SER-CAT
OpenAlex ID: W4408527768
